The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Book brings together works by Palestinian children
- Somalia receives debt relief, financial aid
- Brazilian economy grows 2.7% in 12 months
- Libya seeks closer trade ties with Brazil
- Avian flu: Middle East trusted Brazil
- Bahrain: Passenger traffic up 18% at Gulf Air
- Pope Leo XIV concludes trip to Lebanon
- UAE: Destination of Brazil’s defense products
